BACKGROUND: @entity439 attributable to @entity66 ( @entity66 ) are not common but are associated with a poor prognosis because of a high risk of @entity397 . Special considerations are required for vascular intervention, because the intense local inflammation may increase complications. The aim of this study was to assess the outcome of operative intervention and the use of perioperative medical therapy for @entity439 in @entity1 with @entity66 . MATERIALS AND METHODS: We reviewed retrospectively the medical records of @entity1 with @entity66 admitted to Peking Union Medical College Hospital between January 1995 and January  2015. RESULTS: Among 874 @entity1 diagnosed with @entity66 , 176 @entity1 had vascular involvement, of whom 59 had @entity438 . Thirty-six @entity1 with 51 @entity438 underwent operative intervention. The 51 primary operative interventions included 20 open operations and 31 endovascular interventions. Eleven (22 %) recurrent @entity439 in 10 @entity1 and 5 (10%) @entity715 occurred in 5 @entity1 . Of the 19 endovascular stents placed for @entity449 , 1 type I endoleak, 1 graft occlusion, 3 recurrent @entity439 , and 1 recurrent @entity1756 occurred. Among the revascularization procedures for extremity arteries, there were more complications with endovascular intervention than with open surgery. The cumulative risk of recurrent aneurysmal formation at the operative site was significantly less in @entity1 treated with operative intervention combined with use of immunosuppressants than those treated with operative intervention alone (P  =  .01). CONCLUSION: In @entity1 with @entity66 , an endovascular approach is feasible and effective for @entity449 , whereas bypass surgery appears to provide better outcomes for extremity @entity438 than placement of endovascular stents. The administration of @entity288 combined with @entity786 perioperatively decreases the cumulative risk of recurrent @entity439 .

Outcomes of vascular intervention and  use of perioperative medications for XXXX in @entity66 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity449 :: ('MESH:D001014', 'Disease') :: ['aortic aneurysms'] @entity66 :: ('MESH:D004194', 'Disease') :: ['Beh  et disease', 'BD'] @entity1756 :: ('MESH:D017542', 'Disease') :: ['aneurysmal rupture'] @entity786 :: ('MESH:D003520', 'Chemical') :: ['cyclophosphamide'] @entity288 :: ('MESH:D000305', 'Chemical') :: ['corticosteroids'] @entity397 :: ('MESH:D012421', 'Disease') :: ['rupture'] @entity439 :: ('MESH:D000783', 'Disease') :: ['aneurysms', 'aneurysms developed', 'aneurysm', 'Aneurysms'] @entity715 :: ('MESH:D013927', 'Disease') :: ['thrombosis'] @entity438 :: ('MESH:D002532', 'Disease') :: ['arterial aneurysms']
@entity439 :: (MESH:D000783,Disease) :: ['nonpulmonary aneurysms']
